Toronto, Canada

Viventia Biotech Inc.


USPTO Granted Patents = 5

% Expired Patents = 20.0


Forward Citations = 76

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Pradip K Maiti (3 out of 7 patents)

silverMedal Michael D Dan (3 out of 5 patents)

bronzeMedal Howard A Kaplan (2 out of 2 patents)

4.  Mark C Glassy (1 out of 13 patents)

5.  Albert D Friesen (1 out of 5 patents)

6.  Carol Grad, Legal Representative (1 out of 1 patent)

7.  Keiji Koda (1 out of 2 patents)

8.  Helena R Chang (1 out of 2 patents)

9.  Nicholas Ronald Glover (13 patents)

10.  Jeannick Cizeau (17 patents)

11.  Joycelyn Entwistle (9 patents)

12.  Denis Georges Bosc (3 patents)

13.  Koen Hellendoorn (9 patents)

14.  Francis J Carr (30 patents)

15.  Matthew Baker (0 patent)


5 patents:

Company Overview
Viventia Biotech Inc. is a biopharmaceutical company focused on developing novel cancer therapies. With a team of experienced scientists and researchers, we are dedicated to bringing innovative treatments to patients in need. Our cutting-edge approach to drug development has led to promising results in preclinical studies. Visit our website to learn more about our pipeline and our commitment to advancing oncology care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#283 in Toronto

#2,850 in Canada

Toronto, CA
Toronto, Canada
Forward Citations = 76

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viventia Biotech Inc.. Retrieved from https://idiyas.com/company/viventia-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…